Drug company executives sacked after allegations of illegal surveillanceBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7392.730/d (Published 05 April 2003) Cite this as: BMJ 2003;326:730
- Carl Kovac
Two executives at Lilly Hungaria, the Hungarian subsidiary of US pharmaceutical giant Eli Lilly, have been dismissed after allegations that they ordered the illegal surveillance of officials of the National Health Fund, the body that manages the government budget for health care. The officials have the power to influence decisions on state drug subsidies.
The company's membership of the Association of Innovative Drug Producers has been suspended. The association has issued a statement saying that “Lilly Hungaria has admitted to making a mistake and claims they are taking the necessary steps to investigate the case within the company.”
The alleged …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial